Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Stemtech (STEK) EPS (Weighted Average and Diluted) (2021 - 2025)

Stemtech's EPS (Weighted Average and Diluted) history spans 6 years, with the latest figure at -$0.01 for Q3 2025.

  • On a quarterly basis, EPS (Weighted Average and Diluted) changed 0.0% to -$0.01 in Q3 2025 year-over-year; TTM through Sep 2025 was -$0.02, a 66.67% increase, with the full-year FY2024 number at -$0.03, up 57.14% from a year prior.
  • EPS (Weighted Average and Diluted) hit -$0.01 in Q3 2025 for Stemtech, down from -$0.0 in the prior quarter.
  • Over the last five years, EPS (Weighted Average and Diluted) for STEK hit a ceiling of $0.38 in Q3 2022 and a floor of -$0.56 in Q2 2022.
  • Historically, EPS (Weighted Average and Diluted) has averaged -$0.02 across 5 years, with a median of -$0.01 in 2022.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): skyrocketed 370.0% in 2021 and later crashed 2700.0% in 2022.
  • Tracing STEK's EPS (Weighted Average and Diluted) over 5 years: stood at $0.27 in 2021, then plummeted by 103.7% to -$0.01 in 2022, then plummeted by 100.0% to -$0.02 in 2023, then surged by 83.29% to -$0.0 in 2024, then plummeted by 199.3% to -$0.01 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for STEK at -$0.01 in Q3 2025, -$0.0 in Q2 2025, and -$0.01 in Q1 2025.